We use cookies so our web site can function correctly. By clicking "OK" or by clicking into any content on this site, you agree to allow cookies to be placed.

Privacy Statement

A cookie is a small file which asks permission to be placed on your computer's hard drive. Once you agree, the file is added and the cookie helps analyse web traffic or lets you know when you visit a particular site. Cookies allow web applications to respond to you as an individual. The web application can tailor its operations to your needs, likes and dislikes by gathering and remembering information about your preferences.

We use traffic log cookies to identify which pages are being used. This helps us analyse data about web page traffic and improve our website in order to tailor it to customer needs. We only use this information for statistical analysis purposes.

Overall, cookies help us provide you with a better website, by enabling us to monitor which pages you find useful and which you do not. A cookie in no way gives us access to your computer or any information about you, other than the data you choose to share with us.

Cookie group mandatory

(Req)
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms.
You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

These cookies are required

Functional

These cookies allow us to adtertise our products to you and allow us to pass this information on to our trusted third parties so that they can advertise our products to you on our behalf
All information these cookies collect is aggregated and therefore anonymous. No personal inforation is shared to third parties. Any personal information collected while using our website could be used for direct marketing from HCA only

Marketing

These cookies allow us to advertise our products to you and allow us to pass this information on to our trusted third parties so that they can advertise our products to you on our behalf
All information these cookies collect is aggregated and therefore anonymous. No personal inforation is shared to third parties. Any personal information collected while using our website could be used for direct marketing from HCA only

Performance Cookies

These cookies allow us to know which pages are the most and least popular and see how visitors move around the site.  All information collect is annonomas unless you provide personal information to us.
If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

MS Stem Cell Transplant

Autologous Haematopoietic Stem Cell Transplant

Also known as AHSCT or HSCT, this treatment reboots the immune system to halt the progression of MS.

HSCT therapy for MS

For those with Multiple Sclerosis in whom first line therapies have not worked, HSCT offers the most exciting treatment yet – a true breakthrough in the fight against this debilitating condition.

 

HSCT aims to ‘reboot’ the immune system, to stop it attacking itself and repair any existing damage. It uses chemotherapy to wipe out harmful cells and then reset the immune system using stem cells found in your bone marrow, known as haematopoietic stem cells. Watch our animation to follow the key stages of treatment.

Suitability for HSCT

Stem cell transplantation treatment of this kind is a highly specialised, intensive procedure. Hear Dr Ben Turner, Consultant Neurologist discuss the suitability of patients undergoing this treatment and why they must meet the following criteria:

  • If you have primary, progressive MS (PPMS), you need a lumbar puncture with oligoclonal bands.
  • If you have relapsing remitting MS, you have to fulfil the McDonald criteria.
  • Be between the ages of 18 and 65.
  • Received a diagnosis of MS within the last 15 years.
  • Have a mobility score between 0 – 6.5 (walking with bilateral assistance such as two sticks or a rollator frame).

HSCT at HCA UK

London Bridge Hospital is ideally placed to offer this state-of-the-art therapy, led by one of the pioneers in HSCT for autoimmune disease in the UK, Dr Majid Kazmi, Consultant Haematologist.


Providing this treatment requires the highest levels of experience, clinical quality, appropriate back-up expertise and patient support through the prolonged recovery period.

A JACIE accredited centre

Set in an accredited clinical environment and in the comfort of first-class facilities, HSCT at London Bridge Hospital is primed to transform the lives of patients with MS.


Having carried out over 200 transplants across London’s teaching hospitals, the team have vast experience in this game-changing therapy and include specialist HSCT neurologists and haematologists, clinical nurse specialists, pharmacists, physiotherapists, occupational therapists and dietitians.

 

Ask the HSCT expert - Wednesday 26 May 2021

Our lead neurologists and haematologists will be live and available to answer all your questions in our MS HSCT focussed webinar. Suitable for those with MS, friends and family who would like to know more or healthcare professionals looking for a greater understanding of treatment options. We’ll be sharing the latest insight from the pan-London MDT, discussing current research and data and the impact COVID-19 is having on availability of treatment.

Hear from the specialist team at London Bridge Hospital including Dr Majid Kazmi and Dr Ian Gabriel, Consultant Haematologists and Dr Ben Turner, Consultant Neurologist.

How to get referred

Your consultant neurologist or GP should provide the following information:
  • Documented diagnosis of Multiple Sclerosis by a neurologist with the date of the diagnosis.
  • A record of the ability to walk 20 metres without resting or needing, at most, bilateral assistance with two sticks or a rollator frame.
  • If you have relapsing MS, documentation to show that treatment with one of the high-efficacy disease modifying drugs has been unsuccessful.
  • If no high-efficacy DMT has been tried, the reason for moving directly to HSCT needs to be recorded.
  • MRI scans showing activity within the last 12 months compared to a comparative scan that was done in the previous two to three years. The radiology reports from both time frames should be included with the written referral.

This information will form the basis for an initial consultation with your assigned neurologist, Dr Ben Turner, Dr Eli Silber or Dr Richard Nicholas

Call 02039 938 039 to arrange an appointment

Our stem cell transplant locations

Contact us

If you would like to know more about Autologous Haematopoietic Stem Cell Transplantation for MS contact us today.

02039 938 039
back to top